GLSI
#3361
Greenwich LifeSciences, Inc. - Common stock
17.7 7 USD
+0.08%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+7.50%
Changement Mensuel
+17.29%
Evolution sur 6 mois
-35.36%
Changement Annuel
+74.22%
Clôture Précédente
16.5 3
Open
16.4 2
Low
16.4 2
High
17.9 7
Financials
- Market Capitalization 260.83 M
- Employee 13
- Founded 2006
- CEO N/A
- Website www.greenwichlifesciences.com
- Headquarter Delaware, United States
- FIGI BBG00V6PT8C7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3356 |  LRMR Larimar Therapeutics, Inc. - Common Stock | 2.53 USD | -5.24% | -12.15% | -34.11% | -39.33% | 262.82 M USD | ||
| 3358 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 3.26 USD | -1.51% | -9.44% | -33.60% | -71.53% | 261.37 M USD | ||
| 3362 |  IPSC Century Therapeutics, Inc. - Common Stock | 1.44 USD | -2.04% | -2.70% | -26.53% | +161.82% | 260.75 M USD | ||
| 3370 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 1.85 USD | -6.09% | -7.50% | -20.94% | +17.09% | 258.14 M USD |